These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Thompson MG; Burgess JL; Naleway AL; Tyner H; Yoon SK; Meece J; Olsho LEW; Caban-Martinez AJ; Fowlkes AL; Lutrick K; Groom HC; Dunnigan K; Odean MJ; Hegmann K; Stefanski E; Edwards LJ; Schaefer-Solle N; Grant L; Ellingson K; Kuntz JL; Zunie T; Thiese MS; Ivacic L; Wesley MG; Mayo Lamberte J; Sun X; Smith ME; Phillips AL; Groover KD; Yoo YM; Gerald J; Brown RT; Herring MK; Joseph G; Beitel S; Morrill TC; Mak J; Rivers P; Poe BP; Lynch B; Zhou Y; Zhang J; Kelleher A; Li Y; Dickerson M; Hanson E; Guenther K; Tong S; Bateman A; Reisdorf E; Barnes J; Azziz-Baumgartner E; Hunt DR; Arvay ML; Kutty P; Fry AM; Gaglani M N Engl J Med; 2021 Jul; 385(4):320-329. PubMed ID: 34192428 [TBL] [Abstract][Full Text] [Related]
28. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans. Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401 [TBL] [Abstract][Full Text] [Related]
29. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population. Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. Thompson MG; Stenehjem E; Grannis S; Ball SW; Naleway AL; Ong TC; DeSilva MB; Natarajan K; Bozio CH; Lewis N; Dascomb K; Dixon BE; Birch RJ; Irving SA; Rao S; Kharbanda E; Han J; Reynolds S; Goddard K; Grisel N; Fadel WF; Levy ME; Ferdinands J; Fireman B; Arndorfer J; Valvi NR; Rowley EA; Patel P; Zerbo O; Griggs EP; Porter RM; Demarco M; Blanton L; Steffens A; Zhuang Y; Olson N; Barron M; Shifflett P; Schrag SJ; Verani JR; Fry A; Gaglani M; Azziz-Baumgartner E; Klein NP N Engl J Med; 2021 Oct; 385(15):1355-1371. PubMed ID: 34496194 [TBL] [Abstract][Full Text] [Related]
31. Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes. Magnus MC; Örtqvist AK; Dahlqwist E; Ljung R; Skår F; Oakley L; Macsali F; Pasternak B; Gjessing HK; Håberg SE; Stephansson O JAMA; 2022 Apr; 327(15):1469-1477. PubMed ID: 35323851 [TBL] [Abstract][Full Text] [Related]
32. The relationship between COVID-19 vaccination status in pregnancy and birthweight. Gaur P; Darwin KC; Kohn JR; Uribe KA; Shippey E; Eke AC Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101057. PubMed ID: 37330010 [TBL] [Abstract][Full Text] [Related]
33. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves. Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women. Blakeway H; Amin-Chowdhury Z; Prasad S; Kalafat E; Ismail M; Abdallah FN; Rezvani A; Amirthalingam G; Brown K; Le Doare K; Heath PT; Ladhani SN; Khalil A Ultrasound Obstet Gynecol; 2022 Nov; 60(5):673-680. PubMed ID: 36318630 [TBL] [Abstract][Full Text] [Related]
35. Avoidable intensive care unit resource use and costs of unvaccinated patients with COVID-19: a historical population-based cohort study. Bagshaw SM; Abbott A; Beesoon S; Zuege DJ; Wasylak T; Manns B; Nguyen TX Can J Anaesth; 2022 Nov; 69(11):1399-1404. PubMed ID: 35879485 [TBL] [Abstract][Full Text] [Related]
37. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study. Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921 [TBL] [Abstract][Full Text] [Related]
38. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England. Stowe J; Miller E; Andrews N; Whitaker HJ PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 mRNA vaccination status and concerns among pregnant women in Japan: a multicenter questionnaire survey. Takahashi K; Samura O; Hasegawa A; Okubo H; Morimoto K; Horiya M; Okamoto A; Ochiai D; Tanaka M; Sekiguchi M; Miyasaka N; Suzuki Y; Tabata T; Hayata E; Nakata M; Suzuki T; Nishi H; Toda Y; Tanigaki S; Furuya N; Hasegawa J; Tamaru S; Kamei Y; Sayama S; Nagamatsu T; Takahashi YO; Kitagawa M; Arakaki T; Sekizawa A BMC Pregnancy Childbirth; 2023 May; 23(1):332. PubMed ID: 37161480 [TBL] [Abstract][Full Text] [Related]
40. Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants. Eid J; Abdelwahab M; Williams H; Caplan M; Hajmurad S; Venkatesh KK; Costantine MM; Rood KM Am J Reprod Immunol; 2022 Sep; 88(3):e13596. PubMed ID: 35789021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]